Product Information
SERTRALINE HCL 25 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.0286 per EA under NDC 31722014530. Its NADAC has been published 251 times since Sep 8, 2021.
Strength
25 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722014530
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
SERTRALINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA214790On Market Since
5/3/2021
Pharmacological Classes
Price Statistics
The NADAC for SERTRALINE HCL 25 MG TABLET has been published 251 times since Sep 8, 2021, and over the history we have for it it has declined 58.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0286 per EA |
|---|---|
| All-time high | $0.0743 (Oct 13, 2021) |
| All-time low | $0.0285 (Nov 20, 2024) |
| 52-week high | $0.0336 |
| 52-week low | $0.0286 |
| Median price | $0.0364 |
| Average price | $0.0389 |
| Largest weekly change | -24.8% (Nov 20, 2024) |
| Weeks tracked | 251 |
| Tracking since | Sep 8, 2021 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SERTRALINE HCL 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SERTRALINE HCL 25 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.0286 per EA (NDC 31722014530), effective Jun 24, 2026.
How has the price of SERTRALINE HCL 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for SERTRALINE HCL 25 MG TABLET has declined 58.1%. It has been tracked across 251 weekly CMS publications since Sep 8, 2021.
What are the highest and lowest recorded NADAC prices for SERTRALINE HCL 25 MG TABLET?
Since Sep 8, 2021, the NADAC for SERTRALINE HCL 25 MG TABLET has ranged from a low of $0.0285 (Nov 20, 2024) to a high of $0.0743 (Oct 13, 2021), with a median of $0.0364 per EA.
Are there cheaper alternatives to SERTRALINE HCL 25 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as SERTRALINE HCL 25 MG TABLET, but none are currently priced below it.
Who manufactures SERTRALINE HCL 25 MG TABLET?
SERTRALINE HCL 25 MG TABLET (NDC 31722014530) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification